DHPCC-9 treatment significantly decreased the volume of Pim-3-overexpressing tumors, suggesting that this compound had been able to reach the tumor tissue and inhibit Pim-3 activity there (Fig 2B and 2D). This evidence concerns the gene PIM3 and neoplasm.